Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by ProKidney
ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations
March 25, 2024
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney to Participate in Jefferies Biotech on the Bay Summit
February 29, 2024
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer
November 30, 2023
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference
November 21, 2023
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Reports Third Quarter Financial Results
November 14, 2023
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Announces Positive Interim Data from RMCL-002 Phase 2 Clinical Trial of Renal Autologous Cell Therapy (REACT®) for Diabetic CKD and Provides Corporate Updates
November 13, 2023
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Announces Four Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2023
October 30, 2023
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference
September 05, 2023
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Reports Second Quarter Financial Results and Recent Corporate Highlights
August 10, 2023
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Announces Closing of Purchase of Manufacturing Facility in Greensboro, NC
July 18, 2023
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Appoints Bruce Culleton, MD, as Executive Vice President, Clinical Development and Commercialization
July 17, 2023
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Announces Purchase of Manufacturing Facility in Greensboro, NC
June 13, 2023
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney to Participate in Fireside Chat at the Jefferies Healthcare Conference
June 01, 2023
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Reports First Quarter Financial Results and Recent Corporate Highlights
May 11, 2023
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney to Present at the BofA Securities Health Care Conference 2023
May 04, 2023
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Reports Fourth Quarter Financial Results and Recent Corporate Highlights
March 28, 2023
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney to Participate in TD Cowen’s 43rd Annual Health Care Conference
March 03, 2023
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Announces Publication of Trial Design for Phase 2 Multicenter Clinical Trial of REACT for Late Stage 4 Diabetes-Related Chronic Kidney Disease
January 10, 2023
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
November 14, 2022
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney to Participate in Upcoming Investor Conferences
November 11, 2022
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Receives Allowance from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for proact 1 (REGEN-006) and EMA Scientific Advice on Phase 3 Protocols of REACT for Diabetic Chronic Kidney Disease
November 03, 2022
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
ProKidney Announces Multiple Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2022
October 14, 2022
From
ProKidney
Via
GlobeNewswire
Tickers
PROK
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.